SCHEMBL10575145

SCHEMBL10575145

COc1ccc(-c2nc3cc(C(C)(C)CNS(C)(=O)=O)ccc3[nH]2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 5/20 0.47
▸ NPC1 O15118 4/20 0.47
▸ RAB9A P51151 3/20 0.47
▸ ALDH1A1 P00352 3/20 0.47
▸ PKM P14618 2/20 0.47
▸ KDM4E B2RXH2 2/20 0.47
▸ SLC2A1 P11166 1/20 0.46
▸ CHEK2 O96017 6/20 0.43
▸ MAPT P10636 2/20 0.43
▸ MEN1 O00255 2/20 0.43
▸ LMNA P02545 2/20 0.43
▸ KMT2A Q03164 2/20 0.43
▸ TRPV1 Q8NER1 2/20 0.43
▸ NFKB1 P19838 2/20 0.43
▸ NFKB2 Q00653 2/20 0.43
▸ RELA Q04206 2/20 0.43
▸ GAA P10253 1/20 0.43
▸ MAPK1 P28482 1/20 0.43
▸ STAT1 P42224 1/20 0.43
▸ HTT P42858 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10575156 0.92 SLC2A1 (0.54) SMN1; SMN2NPC1RAB9AALDH1A1PKM
SCHEMBL10578101 0.90 TRPV1 (0.46) SMN1; SMN2NPC1RAB9AALDH1A1PKM
SCHEMBL10572942 0.89 SMN1; SMN2 (0.45) SMN1; SMN2NPC1RAB9AALDH1A1PKM
SCHEMBL10576972 0.88 SMN1; SMN2 (0.44) SMN1; SMN2NPC1RAB9AALDH1A1PKM
SCHEMBL10573685 0.87 SMN1; SMN2 (0.50) SMN1; SMN2NPC1RAB9AALDH1A1PKM
SCHEMBL10578118 0.86 SCD (0.46) SMN1; SMN2NPC1RAB9AALDH1A1KDM4E
SCHEMBL10574269 0.84 NPC1 (0.48) SMN1; SMN2NPC1RAB9AALDH1A1PKM
SCHEMBL10574975 0.82 SMN1; SMN2 (0.46) SMN1; SMN2NPC1RAB9AALDH1A1PKM
SCHEMBL10578112 0.82 TRPV1 (0.53) SMN1; SMN2NPC1RAB9AALDH1A1PKM
SCHEMBL10573902 0.81 NPC1 (0.54) SMN1; SMN2NPC1RAB9AALDH1A1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4882342-A CARDIOVASCULAR DISORDERS BOEHRINGER MANNHEIM GMBH (DE) 1989-11-21 — — US disclosed
EP-0266558-A2 5-Alkylbenzimidazoles, process for their preparation and medicaments containing them Roche Diagnostics GmbH (DE) 1988-05-11 — — EP disclosed
Send feedback